Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Tímea Tőkés

3PUBLICATIONS

0CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Aug 26, 2019

Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer.

Tímea Tőkés, Anna-Mária Tőkés, Gyöngyvér Szentmártoni

|Jul 05, 2019

Influence of mutagenic versus non-mutagenic pre-operative chemotherapy on the immune infiltration of residual breast cancer.

Anna-Mária Tőkés, Orsolya Rusz, Gábor Cserni

|Apr 04, 2019

Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations.

Kornélia Kajáry, Zsolt Lengyel, Anna-Mária Tőkés

Pageof 1

Frequent Collaborators

Frequent Collaborators

Top Related Videos

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA <em>In Situ</em> Hybridization

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA <em>In Situ</em> Hybridization

Published on : Jun 07, 2016

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on : Jul 21, 2018

See more related videos

Top Related Videos

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA <em>In Situ</em> Hybridization

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA <em>In Situ</em> Hybridization

Published on : Jun 07, 2016

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on : Jul 21, 2018

See more related videos